For: | Chen XZ, Jiang K, Hu JK, Zhang B, Gou HF, Yang K, Chen ZX, Chen JP. Cost-effectiveness analysis of chemotherapy for advanced gastric cancer in China. World J Gastroenterol 2008; 14(17): 2715-2722 [PMID: 18461656 DOI: 10.3748/wjg.14.2715] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i17/2715.htm |
Number | Citing Articles |
1 |
Xin-Zu Chen, Shao-Yong Wang, Yin-Su Wang, Zi-Han Jiang, Wei-Han Zhang, Kai Liu, Kun Yang, Xiao-Long Chen, Lin-Yong Zhao, Meng Qiu, Hong-Feng Gou, Zong-Guang Zhou, Jian-Kun Hu. Comparisons of short-term and survival outcomes of laparoscopy-assisted versus open total gastrectomy for gastric cancer patients. Oncotarget 2017; 8(32): 52366 doi: 10.18632/oncotarget.17019
|
2 |
Xin-Zu Chen, Jian-Kun Hu, Kun Yang, Li Wang, Qing-Chun Lu. Short-term Evaluation of Laparoscopy-assisted Distal Gastrectomy for Predictive Early Gastric Cancer. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 2009; 19(4): 277 doi: 10.1097/SLE.0b013e3181b080d3
|
3 |
David M. Meads, Andrea Marshall, Claire T. Hulme, Janet A. Dunn, Hugo E. R. Ford. The Cost Effectiveness of Docetaxel and Active Symptom Control versus Active Symptom Control Alone for Refractory Oesophagogastric Adenocarcinoma: Economic Analysis of the COUGAR-02 Trial. PharmacoEconomics 2016; 34(1): 33 doi: 10.1007/s40273-015-0324-5
|
4 |
Xiaoxiao Li, Ruyong Yao, Lu Yue, Wensheng Qiu, Weiwei Qi, Shihai Liu, Yasai Yao, Jun Liang.
FOXM
1 mediates resistance to docetaxel in gastric cancer
via
up‐regulating Stathmin
. Journal of Cellular and Molecular Medicine 2014; 18(5): 811 doi: 10.1111/jcmm.12216
|
5 |
Yang-Chun Zhou, Hai-Jian Zhao, Li-Zong Shen. Preoperative Serum CEA and CA19-9 in Gastric Cancer - a Single Tertiary Hospital Study of 1,075 Cases. Asian Pacific Journal of Cancer Prevention 2015; 16(7): 2685 doi: 10.7314/APJCP.2015.16.7.2685
|
6 |
Xu Jian-bo, Wu Hui, He Yu-long, Zhang Chang-hua, Zhang Long-juan, Cai Shi-rong, Zhan Wen-hua. Astrocyte-elevated gene-1 overexpression is associated with poor prognosis in gastric cancer. Medical Oncology 2011; 28(2): 455 doi: 10.1007/s12032-010-9475-6
|
7 |
Bo Chen, Yong Zhou, Ping Yang, Liu Liu, Xian-Peng Qin, Xiao-Ting Wu. CDH1 −160C>A gene polymorphism is an ethnicity-dependent risk factor for gastric cancer. Cytokine 2011; 55(2): 266 doi: 10.1016/j.cyto.2011.04.008
|
8 |
Xin-Zu Chen, Jian-Kun Hu, Zong-Guang Zhou, Yuan-Yi Rui, Kun Yang, Li Wang, Bo Zhang, Zhi-Xin Chen, Jia-Ping Chen. Meta-Analysis of Effectiveness and Safety of D2 Plus Para-Aortic Lymphadenectomy for Resectable Gastric Cancer. Journal of the American College of Surgeons 2010; 210(1): 100 doi: 10.1016/j.jamcollsurg.2009.09.033
|
9 |
Xiaojing Zhang, Haixia Zhu, Xiaomin Wu, Meilin Wang, Dongying Gu, Weida Gong, Zhi Xu, Yongfei Tan, Yongling Gong, Jianwei Zhou, Cuiju Tang, Na Tong, Jinfei Chen, Zhengdong Zhang, Xiaoping Miao. A Genetic Polymorphism in TOX3 Is Associated with Survival of Gastric Cancer in a Chinese Population. PLoS ONE 2013; 8(9): e72186 doi: 10.1371/journal.pone.0072186
|
10 |
Lian Xue, Xiao-Long Chen, Wei-Han Zhang, Kun Yang, Xin-Zu Chen, Bo Zhang, Zhi-Xin Chen, Jia-Ping Chen, Zong-Guang Zhou, Jian-Kun Hu. Risk Factors and Prognostic Significance of Retropancreatic Lymph Nodes in Gastric Adenocarcinoma. Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/367679
|
11 |
Tan Chongqing, Peng Liubao, Zeng Xiaohui, Li Jianhe, Wan Xiaomin, Chen Gannong, Wang Siying, Ouyang Lihui, Zhao Ziying. Cost–Utility Analysis of the Newly Recommended Adjuvant Chemotherapy for Resectable Gastric Cancer Patients in the 2011 Chinese National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Gastric Cancer. PharmacoEconomics 2014; 32(3): 235 doi: 10.1007/s40273-013-0065-2
|
12 |
Xin-Zu Chen, Wei-Han Zhang, Jian-Kun Hu. Individualized proximal margin for early gastric cancer patients. World Journal of Gastroenterology 2014; 20(44): 16793-16794 doi: 10.3748/wjg.v20.i44.16793
|
13 |
Hao Lai, Qinwen Jin, Yuan Lin, Xianwei Mo, Bo Li, Ke He, Jiansi Chen. Combined use of lysyl oxidase, carcino-embryonic antigen, and carbohydrate antigens improves the sensitivity of biomarkers in predicting lymph node metastasis and peritoneal metastasis in gastric cancer. Tumor Biology 2014; 35(10): 10547 doi: 10.1007/s13277-014-2355-5
|
14 |
Bo Chen, Yong Zhou, Ping Yang, Xiao-Ting Wu. ERCC2 Lys751Gln and Asp312Asn polymorphisms and gastric cancer risk: a meta-analysis. Journal of Cancer Research and Clinical Oncology 2011; 137(6): 939 doi: 10.1007/s00432-010-0956-y
|
15 |
Xiao-Long Chen, Xin-Zu Chen, Chen Yang, Yan-Biao Liao, He Li, Li Wang, Kun Yang, Ka Li, Jian-Kun Hu, Bo Zhang, Zhi-Xin Chen, Jia-Ping Chen, Zong-Guang Zhou, Wael El-Rifai. Docetaxel, Cisplatin and Fluorouracil (DCF) Regimen Compared with Non-Taxane-Containing Palliative Chemotherapy for Gastric Carcinoma: A Systematic Review and Meta-Analysis. PLoS ONE 2013; 8(4): e60320 doi: 10.1371/journal.pone.0060320
|
16 |
Jiehua Cheng, Yu Zhang, Ailin Zhong, Miao Tian, Guanyang Zou, Xiaping Chen, Hongxing Yu, Fujian Song, Shangcheng Zhou. Quality of Health Economic Evaluations in Mainland China: A Comparison of Peer-Reviewed Articles in Chinese and in English. Applied Health Economics and Health Policy 2022; 20(1): 35 doi: 10.1007/s40258-021-00674-0
|
17 |
Xin-Zu Chen, Wei-Han Zhang, Kun Yang, Bo Zhang, Zhi-Xin Chen, Jia-Ping Chen, Zong-Guang Zhou, Jian-Kun Hu. Quantitative comparisons of summary receiver operating characteristics (sROC) curves among conventional serological tumor biomarkers for predicting gastric cancer in Chinese population. Tumor Biology 2014; 35(9): 9015 doi: 10.1007/s13277-014-1986-x
|
18 |
X. Wang, X. Liu, Y. Jia, Y. Chao, X. Xing, Y. Wang, B. Luo. Widespread sequence variation in the Epstein-Barr virus latent membrane protein 2A gene among northern Chinese isolates. Journal of General Virology 2010; 91(10): 2564 doi: 10.1099/vir.0.021881-0
|
19 |
Lei Wen, Xin-Zu Chen, Kun Yang, Zhi-Xin Chen, Bo Zhang, Jia-Ping Chen, Zong-Guang Zhou, Xian-Ming Mo, Jian-Kun Hu, Rajasingh Johnson. Prognostic Value of Cancer Stem Cell Marker CD133 Expression in Gastric Cancer: A Systematic Review. PLoS ONE 2013; 8(3): e59154 doi: 10.1371/journal.pone.0059154
|
20 |
Michio Kimura, Eiseki Usami, Hitomi Teramachi, Tomoaki Yoshimura. Cost-effectiveness and safety of ramucirumab plus paclitaxel chemotherapy in the treatment of advanced and recurrent gastric cancer. Journal of Oncology Pharmacy Practice 2018; 24(6): 403 doi: 10.1177/1078155217707335
|
21 |
Malihea Khaleghian, Abbas Shakoori, Amirnader Emami Razavi, Cyrus Azimi. Relationship of Amplification and Expression of the C-MYC Gene with Survival among Gastric Cancer Patients. Asian Pacific Journal of Cancer Prevention 2015; 16(16): 7061 doi: 10.7314/APJCP.2015.16.16.7061
|
22 |
Xin-Zu Chen, Jian-Kun Hu, Jin Liu, Kun Yang, Zong-Guang Zhou, Lan-Lan Wang, Chen Yang, Bo Zhang, Zhi-Xin Chen, Jia-Ping Chen. Comparison of short-term outcomes and perioperative systemic immunity of laparoscopy-assisted and open radical gastrectomy for gastric cancer. Journal of Evidence-Based Medicine 2011; 4(4): 225 doi: 10.1111/j.1756-5391.2011.01162.x
|
23 |
Xiao-Long Chen, Kun Yang, Wei-Han Zhang, Xin-Zu Chen, Bo Zhang, Zhi-Xin Chen, Jia-Ping Chen, Zong-Guang Zhou, Jian-Kun Hu, Ferruccio Bonino. Metastasis, Risk Factors and Prognostic Significance of Splenic Hilar Lymph Nodes in Gastric Adenocarcinoma. PLoS ONE 2014; 9(6): e99650 doi: 10.1371/journal.pone.0099650
|
24 |
K. Zhou, F. Wen, P. Zhang, J. Zhou, H. Chen, H. Zheng, Y. Yang, Q. Li. Efficacy and cost-effectiveness of second-line chemotherapy in elderly patients with advanced gastric cancer. Clinical and Translational Oncology 2017; 19(9): 1117 doi: 10.1007/s12094-017-1647-9
|
25 |
Feng Wen, Hanrui Zheng, Pengfei Zhang, Jing Zhou, Hongdou Chen, Kexun Zhou, Qiu Li, Feng Bi. Patient‐based cost‐effectiveness analysis of FOLFIRI versus FOLFOX7 for advanced gastric adenocarcinoma in China: A 4‐year prospective randomised phase II study. European Journal of Cancer Care 2020; 29(1) doi: 10.1111/ecc.13196
|
26 |
Li‑Jie Xia, Yan‑Ling Wu, Fu‑Chun Zhang. Combination of cecropinXJ and LY294002 induces synergistic cytotoxicity, and apoptosis in human gastric cancer cells via inhibition of the PI3K/Akt signaling pathway. Oncology Letters 2017; doi: 10.3892/ol.2017.7112
|
27 |
Xin-Zu Chen, Wei-Han Zhang, Hai-Ning Chen, Jian-Ping Liu, Du He, Yang Liu, Kai Liu, Xiao-Long Chen, Xian-Ming Mo, Zong-Guang Zhou, Jian-Kun Hu. Associations between serum CA724 and HER2 overexpression among stage II-III resectable gastric cancer patients: an observational study. Oncotarget 2016; 7(17): 23647 doi: 10.18632/oncotarget.8145
|
28 |
Gang Zhang, Dongying Gu, Qinghong Zhao, Haiyan Chu, Zhi Xu, Meilin Wang, Cuiju Tang, Dongmei Wu, Na Tong, Weida Gong, Jianwei Zhou, Yong Xu, Zhengdong Zhang, Jinfei Chen. Genetic variation in C12orf51 is associated with prognosis of intestinal-type gastric cancer in a Chinese population. Biomedicine & Pharmacotherapy 2015; 69: 133 doi: 10.1016/j.biopha.2014.11.009
|
29 |
Xiaoxiao Li, Wensheng Qiu, Bin Liu, Ruyong Yao, Shihai Liu, Yasai Yao, Jun Liang. Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel. Journal of Translational Medicine 2013; 11(1) doi: 10.1186/1479-5876-11-204
|
30 |
Xin-Zu Chen, Wei-Ke Zhang, Kun Yang, Lan-Lan Wang, Jin Liu, Li Wang, Jian-Kun Hu, Bo Zhang, Zhi-Xin Chen, Jia-Ping Chen, Zong-Guang Zhou, Xian-Ming Mo. Correlation between serum CA724 and gastric cancer: multiple analyses based on Chinese population. Molecular Biology Reports 2012; 39(9): 9031 doi: 10.1007/s11033-012-1774-x
|